INDEVUS PHARMACEUTICALS INC (IDEV) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 265 transactions totaling $78.8M, demonstrating a bearish sentiment with -$49.8M in net insider flow. The most recent transaction on Mar 23, 2009 involved a purchase of 11,306,421 shares valued at $0.
No significant insider buying has been recorded for IDEV in the recent period.
No significant insider selling has been recorded for IDEV in the recent period.
Based on recent SEC filings, insider sentiment for IDEV is bearish with an Insider Alignment Score of 18/100 and a net flow of -$49.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at INDEVUS PHARMACEUTICALS INC (IDEV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading IDEV stock, having executed 265 transactions in the past 90 days. The most active insider is James C. Gale (Executive), who has made 160 transactions totaling $63.0M.
Get notified when executives and directors at IDEV file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 23, 2009 | Inc. Btb Purchaser | Executive | Purchase | 11,306,421 | $N/A | $0 | |
| Mar 23, 2009 | Inc. Btb Purchaser | Executive | Purchase | 8,619,330 | $N/A | $0 | |
| Mar 19, 2009 | Inc. Btb Purchaser | Executive | Purchase | 438,462 | $N/A | $0 | |
| Mar 18, 2009 | Inc. Btb Purchaser | Executive | Purchase | 197,521 | $N/A | $0 | |
| Mar 17, 2009 | Inc. Btb Purchaser | Executive | Purchase | 287,810 | $N/A | $0 | |
| Mar 16, 2009 | Inc. Btb Purchaser | Executive | Purchase | 3,300,098 | $N/A | $0 | |
| Mar 13, 2009 | Inc. Btb Purchaser | Executive | Purchase | 462,145 | $N/A | $0 | |
| Mar 12, 2009 | Inc. Btb Purchaser | Executive | Purchase | 359,178 | $N/A | $0 | |
| Mar 11, 2009 | Inc. Btb Purchaser | Executive | Purchase | 188,309 | $N/A | $0 | |
| Mar 10, 2009 | Inc. Btb Purchaser | Executive | Purchase | 111,250 | $N/A | $0 | |
| Mar 7, 2009 | Holdings Inc Endo Pharmaceuticals | Executive | Purchase | 520,180 | $N/A | $0 | |
| Mar 6, 2009 | Holdings Inc Endo Pharmaceuticals | Executive | Purchase | 206,615 | $N/A | $0 | |
| Mar 5, 2009 | Holdings Inc Endo Pharmaceuticals | Executive | Purchase | 1,022,729 | $N/A | $0 | |
| Mar 4, 2009 | Inc. Btb Purchaser | Executive | Purchase | 3,500 | $N/A | $0 | |
| Mar 4, 2009 | Holdings Inc Endo Pharmaceuticals | Executive | Purchase | 3,500 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 124 | $64.3M | 64.3% |
Purchase(P) | 33 | $14.5M | 14.5% |
Other(J) | 31 | $11.0M | 10.9% |
Tender(U) | 26 | $10.0M | 10.0% |
Disposition(D) | 8 | $96.6K | 0.1% |
Award(A) | 29 | $92.3K | 0.1% |
Exercise(M) | 13 | $27.9K | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider selling pressure at INDEVUS PHARMACEUTICALS INC has increased, with 18 insiders executing 265 transactions across all time. Total sales of $64.3M significantly outpace purchases of $14.5M, resulting in a net outflow of $49.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.